company background image
FLRY3 logo

Fleury BOVESPA:FLRY3 Lagerbericht

Letzter Preis

R$13.54

Marktkapitalisierung

R$7.5b

7D

-3.0%

1Y

-20.6%

Aktualisiert

18 Nov, 2024

Daten

Finanzdaten des Unternehmens +

Fleury S.A.

BOVESPA:FLRY3 Lagerbericht

Marktkapitalisierung: R$7.5b

FLRY3 Aktienübersicht

Fleury S.A. bietet zusammen mit seinen Tochtergesellschaften medizinische Dienstleistungen in den Bereichen Diagnose, Behandlung, klinische Analyse, Gesundheitsmanagement, medizinische Versorgung, Orthopädie und Augenheilkunde in Brasilien an. Mehr Details

FLRY3 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung5/6
Künftiges Wachstum2/6
Vergangene Leistung5/6
Finanzielle Gesundheit4/6
Dividenden4/6

Belohnungen

36.3% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 13.82% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 64.3%

Analysten sind sich einig, dass der Aktienkurs um 41%

Risikoanalyse

Unbeständige Dividendenentwicklung


Fleury S.A. Wettbewerber

Oncoclínicas do Brasil Serviços Médicos

BOVESPA:ONCO3

R$2.5b

Odontoprev

BOVESPA:ODPV3

R$5.6b

Rede D'Or São Luiz

BOVESPA:RDOR3

R$66.1b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$864.4m

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Fleury
Historische Aktienkurse
Aktueller AktienkursR$13.54
52-Wochen-HochR$18.96
52-Wochen-TiefR$13.46
Beta0.60
11 Monat Veränderung-9.25%
3 Monate Veränderung-14.52%
1 Jahr Veränderung-20.63%
33 Jahre Veränderung-24.01%
5 Jahre Veränderung-50.06%
Veränderung seit IPO55.80%

Aktuelle Nachrichten und Updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Recent updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Apr 16
The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Jan 05
Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Oct 05
Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 27
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Feb 25
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Sep 26
At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Sep 08
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Jul 01
Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Jun 10
When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Apr 10
Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Mar 24
Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Feb 08
At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Dec 08
Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 05
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Oct 21
Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Aug 24
Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Jul 31
Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Jul 07
Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Apr 30
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

Apr 12
Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Mar 29
At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Mar 16
Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Mar 01
Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28
Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15
What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02
Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28
Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12
Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29
Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30
Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18
Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03
Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aktionärsrenditen

FLRY3BR HealthcareBR Markt
7D-3.0%0.3%-0.06%
1Y-20.6%-13.6%-1.6%

Rendite im Vergleich zur Industrie: FLRY3 unter dem Niveau der Branche BR Healthcare , die im vergangenen Jahr eine Rendite von -13.6% erzielte.

Rendite vs. Markt: FLRY3 hinter dem Markt BR zurück, der im vergangenen Jahr eine Rendite von -1.6 erzielte.

Preisvolatilität

Is FLRY3's price volatile compared to industry and market?
FLRY3 volatility
FLRY3 Average Weekly Movement3.1%
Healthcare Industry Average Movement6.1%
Market Average Movement4.5%
10% most volatile stocks in BR Market8.5%
10% least volatile stocks in BR Market2.3%

Stabiler Aktienkurs: FLRY3 hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: FLRY3Die wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
192627,000Jeane Tsutsuiri.fleury.com.br

Fleury S.A. bietet zusammen mit seinen Tochtergesellschaften medizinische Dienstleistungen in den Bereichen Diagnose, Behandlung, klinische Analyse, Gesundheitsmanagement, medizinische Versorgung, Orthopädie und Augenheilkunde in Brasilien an. Das Unternehmen ist in drei Segmenten tätig: Diagnostische Medizin, Integrierte Medizin und Zahnmedizin. Es bietet Labor- und Bildgebungstests, Genomik, Gesundheitsmanagement und -plattform, diagnostische Informationen, Check-up und Referenzlabor, Kliniktag, Infusionszentrum, Orthopädie und Augenheilkunde, zahnmedizinische Bildgebungstests und diagnostische Bildgebungsdienste.

Fleury S.A.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Fleury im Vergleich zum Marktanteil des Unternehmens?
FLRY3 grundlegende Statistiken
MarktanteilR$7.49b
Gewinn(TTM)R$613.53m
Umsatz(TTM)R$7.55b

12.0x

Kurs-Gewinn-Verhältnis

1.0x

Kurs-Umsatz-Verhältnis

Ist FLRY3 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
FLRY3 Gewinn- und Verlustrechnung (TTM)
EinnahmenR$7.55b
Kosten der EinnahmenR$5.46b
BruttogewinnR$2.09b
Sonstige AusgabenR$1.48b
UmsatzR$613.53m

Zuletzt gemeldete Gewinne

Sep 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)1.13
Bruttomarge27.69%
Nettogewinnspanne8.13%
Schulden/Eigenkapital-Verhältnis71.2%

Wie hat sich FLRY3 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

4.3%

Aktuelle Dividendenrendite

13%

Ausschüttungsquote